4.6 Review

FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities

期刊

TRENDS IN IMMUNOLOGY
卷 36, 期 6, 页码 325-336

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.it.2015.04.005

关键词

Fc receptor; immunoglobulin G; agonistic antibody; neutralizing antibody; cytotoxicity

资金

  1. German Research Foundation [TRR130, SFB 643, SPP1468, GK1660]
  2. Sander Foundation
  3. Bill and Melinda Gates Foundation

向作者/读者索取更多资源

Given the widespread use of antibodies of the immunoglobulin G (IgG) class as cytotoxic, immunomodulatory, and neutralizing agents in the therapy of malignant, infectious, and autoimmune diseases, understanding the molecular and cellular mechanisms responsible for their therapeutic activity is of major importance. While Fc gamma receptors (Fc gamma R) have well-appreciated roles as effectors of cytotoxic IgG activity, it has only recently become clear that the functionality of immunomodulatory and neutralizing IgG preparations also depends on cellular Fc gamma Rs. Here, we review current models of IgG activity in infectious and inflammatory settings, and examine the importance of cell type-specific expression of Fc gamma Rs in determining functional outcome. We discuss how this knowledge may be used to improve the activity of therapeutic antibody preparations and outline important areas of focus for future research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Hematology

Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy

Katja Klausz, Michael Cieker, Christian Kellner, Thies Roesner, Anna Otte, Steffen Krohn, Anja Lux, Falk Nimmerjahn, Thomas Valerius, Martin Gramatzki, Matthias Peipp

Summary: The novel therapeutic antibody TP15, targeting ICAM-1, showed significant anti-tumor activity by inducing antibody-dependent cell-mediated cytotoxicity. It prevented myeloma cell engraftment and prolonged survival in a mouse model, demonstrating potential for myeloma immunotherapy.

HAEMATOLOGICA (2021)

Article Immunology

Complement-Dependent Activity of CD20-Specific IgG Correlates With Bivalent Antigen Binding and C1q Binding Strength

Sina Bondza, Anita Marosan, Sibel Kara, Josephine Loesing, Matthias Peipp, Falk Nimmerjahn, Jos Buijs, Anja Lux

Summary: Monoclonal antibodies targeting CD20 on B cells are commonly used in therapy, with differences in their mechanisms of inducing B cell depletion, particularly in terms of complement activation.

FRONTIERS IN IMMUNOLOGY (2021)

Editorial Material Immunology

Four keys to unlock IgG

Falk Nimmerjahn, Jeffrey V. Ravetch

Summary: The study by Grey and Kunkel in 1964 laid the groundwork for our current understanding of the differential IgG subclass activity in protective and self-reactive immune responses.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

Select hyperactivating NLRP3 ligands enhance the TH1-and TH17-inducing potential of human type 2 conventional dendritic cells

Lukas Hatscher, Christian H. K. Lehmann, Ariawan Purbojo, Constantin Onderka, Chunguang Liang, Arndt Hartmann, Robert Cesnjevar, Heiko Bruns, Olaf Gross, Falk Nimmerjahn, Ivana Ivanovic-Burmazovic, Meik Kunz, Lukas Heger, Diana Dudziak

Summary: The conventional type 2 DC (cDC2) subset has been found to be transcriptionally and functionally poised for inflammasome formation and response without pyroptosis when stimulated with relatively weak inflammasome activators, leading to the induction of prominent T helper type 1 (T(H)1) and T(H)17 responses. These findings suggest that the human cDC2 subpopulation could be a prime target for the treatment of inflammasome-dependent inflammatory diseases and provide insights for new approaches in adjuvant and vaccine development.

SCIENCE SIGNALING (2021)

Article Oncology

CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity

A. Stoll, H. Bruns, M. Fuchs, S. Voelkl, F. Nimmerjahn, M. Kunz, M. Peipp, A. Mackensen, D. Mougiakakos

Summary: CD137 plays a crucial role in monocytes, and its agonists may have therapeutic implications in combination with tumor-targeting antibodies, potentially showing synergistic effects.

LEUKEMIA (2021)

Article Multidisciplinary Sciences

Targeting B cells in the pre-phase of systemic autoimmunity globally interferes with autoimmune pathology

Anja Werner, Simon Schafer, Olga Zaytseva, Heike Albert, Anja Lux, Jasminka Kristic, Marija Pezer, Gordan Lauc, Thomas Winkler, Falk Nimmerjahn

Summary: Systemic lupus erythematosus (SLE) is characterized by loss of self-tolerance, systemic inflammation, and multi-organ damage. Early diagnosis and treatment are crucial for achieving long-lasting therapeutic responses and limiting irreversible organ damage. Loss of humoral tolerance before clinical autoimmune disease onset provides a potential early intervention point.

ISCIENCE (2021)

Review Clinical Neurology

Next-generation antibody-based therapies in neurology

Tobias Ruck, Falk Nimmerjahn, Heinz Wiendl, Jan D. Luenemann

Summary: Ruck et al. provide an overview of advancements in next-generation antibody-based therapies for brain diseases, focusing on Fc engineering and improving bioavailability in the CNS parenchyma. They discuss the potential benefits and limitations of these therapies in neurology. Antibody-based treatments have become standard in neuroinflammatory diseases, and efforts are being made to expand their use to a wider range of neurological disorders. The specificity and effectiveness of these treatments are determined by engineering the antigen-binding fragment (Fab) and the crystallizable fragment (Fc) of the antibodies. The development of technologies to enhance the bioavailability of these treatments within the brain shows promise for improving options for patients with limited therapeutic choices.
Article Immunology

B-cell modulation with anti-CD79b antibodies ameliorates experimental autoimmune encephalitis in mice

Kerstin Renner, Sophia Neumayer, Yvonne Talke, Simone Buchtler, Kathrin Schmidbauer, Falk Nimmerjahn, Anja Lux, Frederike Winter, Jan-Nicklas Salewski, Matthias Mack

Summary: B-cell modulation through targeting CD79b can achieve therapeutic effects in autoimmune diseases like MS, offering an alternative approach to complete B-cell depletion with anti-CD20 antibodies.

EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

Editorial Material Immunology

HINGEneering IgG for enhanced immune activation

Anja Werner, Falk Nimmerjahn

Summary: Two recent studies in Science Immunology demonstrate that the hinge region of immunoglobulin G (IgG) is a major regulator of IgG2 and IgG3 activity. Engineering of the IgG hinge may be useful for optimizing the activity of IgG subclasses.

SCIENCE IMMUNOLOGY (2022)

Correction Immunology

Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapy (vol 24, pg 1244, 2023)

Falk Nimmerjahn, Gestur Vidarsson, Mark S. S. Cragg

NATURE IMMUNOLOGY (2023)

Review Immunology

Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapy

Falk Nimmerjahn, Gestur Vidarsson, Mark S. Cragg

Summary: Humoral immune responses generate polyclonal antibodies with varied isotypes, epitope specificity, and affinity. Posttranslational modifications in antibody variable and constant domains can modify antigen specificity and antibody Fc-dependent functions. Understanding the impact of these modifications on antibody function is still limited, but it has implications for therapeutic antibody development. This Review provides insights into how IgG subclass and posttranslational modifications influence antibody activity and discusses their implications in designing therapeutic antibodies for different clinical indications.

NATURE IMMUNOLOGY (2023)

Correction Immunology

Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapy (vol 24, 1244, 2023)

Falk Nimmerjahn, Gestur Vidarsson, Mark S. Cragg

NATURE IMMUNOLOGY (2023)

Review Immunology

Tissue-specific macrophages: how they develop and choreograph tissue biology

Elvira Mass, Falk Nimmerjahn, Katrin Kierdorf, Andreas Schlitzer

Summary: Macrophages play important roles in host immunity, waste clearance, metabolism regulation, and neuronal functions. They form a 3D network in tissues and phagocytose dying cells, immune complexes, bacteria, and waste products, while also producing growth factors and signaling molecules. Macrophages are involved in physiological processes such as blood vessel formation, adipogenesis, metabolism, and neuronal function. Different tissue-specific macrophage populations have distinct developmental trajectories, transcriptional programs, and life cycles.

NATURE REVIEWS IMMUNOLOGY (2023)

Letter Biochemistry & Molecular Biology

Response to Oswald et al.: ST6Gal1 in plasma is dispensable for IgG sialylation

Anja Werner, Falk Nimmerjahn

Summary: The presence or absence of terminal sialic acid residues in the sugar moiety attached to the Fc-domain of IgG molecules plays a role in modulating IgG activity and is associated with autoimmune or infection-related inflammation. Recent findings by Oswald and colleagues propose that IgG sialylation may occur post IgG secretion, which has implications for therapeutic antibodies. However, we argue that previous research suggests that IgG sialylation actually occurs within B cells and question the suitability of the experimental system employed by the authors to address this question.

GLYCOBIOLOGY (2022)

暂无数据